Stay updated on SAR444245 and Cemiplimab in Skin Cancers Clinical Trial
Sign up to get notified when there's something new on the SAR444245 and Cemiplimab in Skin Cancers Clinical Trial page.

Latest updates to the SAR444245 and Cemiplimab in Skin Cancers Clinical Trial page
- Check4 days agoChange DetectedRevision: v3.5.3 is now shown in the record history, replacing v3.5.2. This marks a new page revision rather than changes to the study record.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedA new revision entry, v3.5.2, appears in the history, replacing v3.5.0. The update records the page version change rather than altering study information.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedAdded revision entry v3.5.0 to the history and removed the v3.4.3 entry.SummaryDifference0.1%

- Check54 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 from the history.SummaryDifference0.1%

- Check68 days agoChange DetectedA new revision entry has been added to the record history, documenting an update to the study status.SummaryDifference0.1%

- Check82 days agoChange DetectedThe revision adds results-related sections such as Results Posted, Outcome Measures (Results), Adverse Events, Baseline Characteristics, and Participant Flow, along with updated documentation. It also updates Study Status and other study data sections.SummaryDifference2%

Stay in the know with updates to SAR444245 and Cemiplimab in Skin Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAR444245 and Cemiplimab in Skin Cancers Clinical Trial page.